| Name | Ravuconazole | 
|---|---|
| Synonyms | 
                                
                                (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-buta n-2-ol
                                
                                
                                 3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol N-Boc-dolaproline (1R,2R)-4-[2-[2-(2,4-difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl]-benzonitrile (2R,3R)-3-[(2S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl]-3-methoxy-2-methylpropanoic acid N-(tert-Butoxycarbonyl)-(2R,3R,2'S)-dolaproine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid (2R,3R,2'S)-3-(N-tert-butoxycarbonyl-2'-pyrrolidinyl)-3-methoxy-2-methylpropanoic acid (2R,3R,4S)-3-(N-tert-butoxycarbonyl-2'-pyrrolidinyl)-3-methoxy-2-methyl-propanoic acid  | 
                        
| Melting Point | 148-151°C | 
|---|---|
| Molecular Formula | C22H17F2N5OS | 
| Molecular Weight | 437.46500 | 
| Exact Mass | 437.11200 | 
| PSA | 115.86000 | 
| LogP | 4.24298 | 
| Storage condition | -20?C Freezer | 
| 
                                
                                
                                
                                
                                 ~%  
                                    170864-29-6  | 
                        
| Literature: Eisai Co., Ltd. Patent: EP1231210 A2, 2002 ; Location in patent: Page 75 ; |